Fingerprint
Dive into the research topics of 'Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically